Immunosuppressants - PDFSEARCH.IO - Document Search Engine

Immunosuppressants
Results: 1821

#	Item
381	Prospection submission REVIEW OF AUTHORITY REQUIRED PBS LISTINGS DR PETER CRONIN Review of Authority Required PBS Listings Prospection is a health analytics company. We have considerable experience working with the PBS Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-04 00:10:33 Autoimmune diseases Psoriasis Arthritis Immunosuppressants Adalimumab Biologic Psoriatic arthritis Rheumatoid arthritis Indication Medicine Health Pharmacology
382	SCHEDULE OF PHARMACEUTICAL BENEFITS EFFECTIVE 1 SEPTEMBER 2014 ERRATA (1) This Erratum corrects the entry for Olanzapine in the 1 September 2014 Schedule. The following Note should appear in the Schedule entry for all Ol Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-02 00:13:48 Connective tissue diseases Rheumatology Immunosuppressants Pharmacology Tocilizumab Rheumatoid arthritis Nurse practitioner Juvenile idiopathic arthritis Nursing Health Medicine Arthritis
383	Post-market Review of Authority Required PBS Listings: Public Consultation Submission from Biogen Idec (Australia) Pty Ltd regarding disease-modifying therapies for Multiple Sclerosis (first tranche of reviews) Dear PBAC Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-04 00:10:33 Immunosuppressants Cytokines Pharmacology Autoimmune diseases Monoclonal antibodies Biogen Idec Natalizumab Interferon beta-1a Treatment of multiple sclerosis Immunology Immune system Multiple sclerosis
384	SCHEDULE OF PHARMACEUTICAL BENEFITS EFFECTIVE 1 FEBRUARY 2015 ERRATA (1) This Erratum corrects the entry for Olanzapine in the 1 February 2015 Schedule. The following Note should appear in the Schedule entry for all Olan Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-26 18:49:49 Connective tissue diseases Rheumatology Immunosuppressants Pharmacology Tocilizumab Rheumatoid arthritis Nurse practitioner Juvenile idiopathic arthritis Nursing Health Medicine Arthritis
385	HK J Paediatr (new series) 2002;7:[removed]MCQs Instruction: 1. Please use pencil to shade the correct box for the answer sheet (see loose leaf page). 2. Send back the answer sheet to the Hong Kong College of Paediatrici Add to Reading List Source URL: www.fmshk.com.hk Language: English - Date: 2006-06-28 04:18:45 Immunosuppressants Orthomolecular medicine Antihemorrhagics Naphthoquinones Vitamin K Azathioprine Vitamin C Vitamin Vitamin B12 Medicine Nutrition Chemistry
386	PATIENT INFORMATION ON ADALIMUMAB (Brand name: Humira) This information sheet has been produced by the Australian Rheumatology Association to Add to Reading List Source URL: www.rheumatology.org.au Language: English - Date: 2014-03-20 01:02:35 Autoimmune diseases Arthritis Rheumatology Immunosuppressants Monoclonal antibodies Adalimumab Psoriatic arthritis Rheumatoid arthritis Disease-modifying antirheumatic drug Medicine Health Anatomy
387	PATIENT INFORMATION ON GOLD (Examples of brand names: Myocrisin, Ridaura) This information sheet has been produced by the Australian Rheumatology Association to Add to Reading List Source URL: www.rheumatology.org.au Language: English - Date: 2014-01-16 18:35:16 Rheumatology Arthritis Connective tissue diseases Immunosuppressants Aging-associated diseases Rheumatoid arthritis Gold salts Psoriatic arthritis Chrysiasis Health Medicine Anatomy
388	PATIENT INFORMATION ON MYCOPHENOLATE MOFETIL (Brand name: CellCept/Imulate/Ceptolate) AND Add to Reading List Source URL: www.rheumatology.org.au Language: English - Date: 2014-03-20 02:04:45 Medicine Lactones Phenols Autoimmune diseases Mycophenolic acid Mycophenolate mofetil Azathioprine Systemic lupus erythematosus Rheumatoid arthritis Immunosuppressants Chemistry Organic chemistry
389	Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:39:15 Organ failure Immunosuppressants Eculizumab Kidney diseases Hemolytic-uremic syndrome Chronic kidney disease Dialysis Pharmaceutical Benefits Scheme Kidney transplantation Medicine Health Nephrology
390	Outcome Statement of the Paediatric Medicines Advisory Group (PMAG) meeting 31 October 2012 Medicine needs in the paediatric health setting PMAG has identified a priority list of medicines requiring access for paediatric Add to Reading List Source URL: www.health.gov.au Language: English - Date: 2015-03-20 09:36:45 Pharmacology Rheumatology Arthritis Connective tissue diseases Adalimumab Juvenile idiopathic arthritis Anakinra Pharmaceutical Benefits Scheme Etanercept Medicine Immunosuppressants Health

UPDATE